Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tango Therapeutics (TNGX) Assets Average: 2020-2025

Historic Assets Average for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to $224.0 million.

  • Tango Therapeutics' Assets Average fell 38.95% to $224.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.0 million, marking a year-over-year decrease of 38.95%. This contributed to the annual value of $359.5 million for FY2024, which is 14.30% down from last year.
  • Per Tango Therapeutics' latest filing, its Assets Average stood at $224.0 million for Q3 2025, which was down 12.53% from $256.1 million recorded in Q2 2025.
  • Tango Therapeutics' 5-year Assets Average high stood at $515.1 million for Q4 2021, and its period low was $167.9 million during Q2 2021.
  • For the 3-year period, Tango Therapeutics' Assets Average averaged around $355.1 million, with its median value being $391.6 million (2023).
  • In the last 5 years, Tango Therapeutics' Assets Average skyrocketed by 174.28% in 2021 and then slumped by 38.95% in 2025.
  • Quarterly analysis of 5 years shows Tango Therapeutics' Assets Average stood at $515.1 million in 2021, then dropped by 12.59% to $450.3 million in 2022, then declined by 7.76% to $415.4 million in 2023, then fell by 19.48% to $334.5 million in 2024, then plummeted by 38.95% to $224.0 million in 2025.
  • Its last three reported values are $224.0 million in Q3 2025, $256.1 million for Q2 2025, and $295.4 million during Q1 2025.